Brady Corporation (BRC) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company reported strong financial metrics, including record EPS growth and successful acquisitions, despite some challenges in Europe and Australia. The 40th consecutive year of dividend increases and share buybacks signal strong shareholder returns. Although gross margins declined slightly, the company's strategic cost-cutting and tariff mitigation efforts are promising. The Q&A reveals management's confidence in addressing challenges, despite some vague responses. Considering the company's market cap, these factors suggest a positive stock price movement in the short term.
Key Financial Performance
Adjusted EPS Increased by 5.9% year-over-year to $1.26 per share, a new quarterly record. This growth was driven by organic sales growth of 2.4% and acquisitions adding 11.3% to sales growth.
Organic Sales Growth Grew by 2.4% in the quarter, with the Americas and Asia region reporting strong growth of 4.3%. Europe and Australia experienced a decline of 1.3% due to challenging macroeconomic conditions.
R&D Investment Increased by 31% in the fourth quarter, reaching nearly $80 million for the year, or 5.3% of sales. This was driven by investments in organic businesses and acquisitions like Gravotech and Funai's Microfluidics Solutions product line.
Gross Profit Margin Decreased to 50.4% from 51.6% in the prior year. Excluding $1.9 million in cost reduction expenses, the margin would have been 50.9%.
SG&A Expenses Increased to $117.9 million from $93.3 million in the prior year, representing 29.7% of sales compared to 27.2% last year. Excluding certain costs, SG&A was 26.8% of sales compared to 26.5% last year.
Adjusted Pre-Tax Earnings Increased by 5.1% from $70.5 million to $74.2 million, excluding amortization and reorganization costs.
GAAP Net Income Decreased from $55.5 million to $49.9 million year-over-year. Adjusted net income increased by 5.1% from $57.3 million to $60.2 million.
Operating Cash Flow Decreased to $58.3 million from $84 million in the prior year. Free cash flow also decreased to $49.4 million from $73.2 million.
Net Cash Position Stood at $74.6 million as of July 31, 2025, reflecting strong cash generation and disciplined capital allocation.
Americas and Asia Region Sales Sales were $260.8 million, with total growth of 14.1%, including 4.3% organic growth and 9.8% growth from acquisitions. Segment profit decreased by 3.3% to $51.6 million, but increased by 7.5% when excluding certain costs.
Europe and Australia Region Sales Sales were $136.5 million, with organic sales declining by 1.3%. Acquisitions added 14.4% growth, and foreign currency translation added 5.7%. Segment profit decreased by 21.8%, but increased by 7.9% when excluding certain costs.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New flagship printer i7500: Launched in Q2, exceeded sales targets, and received positive customer feedback.
Acquisition of Gravotech and Funai's Microfluidics Solutions: Added technical capabilities to the product portfolio, enhancing growth potential.
R&D investment: Increased by 31% in Q4, reaching nearly $80 million for the year, focusing on high-performance materials and product interoperability.
Americas and Asia region: Strong organic sales growth of 4.3% in Q4 and 4.8% for the year, with Asia (excluding China) showing 23% growth.
Europe and Australia region: Challenging macro environment with a 1.3% organic sales decline in Q4, but reorganization efforts improved operating income by 7.9%.
Cost structure optimization: Facility closures and headcount reductions in Europe, Australia, and China to improve efficiency.
Gross profit margin: Reported at 50.4% in Q4, with adjustments for reorganization costs raising it to 50.9%.
Strategic acquisitions: Acquired Gravotech and Mecco to enhance direct part marking capabilities and integrate technologies.
Shareholder returns: Repurchased 733,000 shares for $51 million and increased dividends for the 40th consecutive year.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Challenging macro environment in Europe and Australia: Organic sales declined 1.3% in the fourth quarter in these regions, with Australia experiencing a 5.1% decline. Economic conditions for industrial manufacturers in these areas are challenging, impacting sales and profitability.
Facility closures and reorganization costs: The company incurred $8.9 million in facility closure and reorganization costs in the fourth quarter, primarily in Europe and Australia, to address declining sales and economic challenges.
Decline in economic activity in China: Sales in China declined approximately 3% due to continued economic slowdown, prompting headcount reductions in several locations.
Tariffs and trade policy risks: Incremental tariff expenses amounted to $7 million in fiscal 2025, with an estimated additional impact of $8 million to $12 million in fiscal 2026, depending on trade policy developments and mitigating actions.
Inflationary pressures: Potential inflationary pressures could impact profitability if not offset in a timely manner.
Strengthening of the U.S. dollar: A stronger U.S. dollar poses a risk to financial performance, particularly in international markets.
Integration challenges with acquisitions: The integration of Gravotech and Mecco into core operations may present operational challenges, particularly in aligning cost structures and achieving synergies.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
EPS Guidance for Fiscal 2026: GAAP EPS is projected to range from $4.55 to $4.85 per share, representing an increase of 15.5% to 23.1% compared to fiscal 2025. Adjusted EPS is expected to range from $4.85 to $5.15 per share, reflecting an increase of 5.4% to 12%.
Organic Sales Growth: Anticipated to grow in the low single-digit percentages for the year ending July 31, 2026.
Capital Expenditures: Projected to be approximately $40 million in fiscal 2026.
Tariff Impact: Estimated additional impact of $8 million to $12 million in fiscal 2026 compared to fiscal 2025, net of mitigating actions.
R&D Investment: Continued focus on increasing R&D investment, with a strong product roadmap and new product launches planned for fiscal 2026.
Regional Performance Outlook: Cost reduction actions in Europe, Australia, and China are expected to improve profitability in fiscal 2026. Organic sales growth in Asia outside of China is expected to remain strong.
Market Trends and Strategic Plans: Focus on workplace automation as a long-term growth opportunity, development of tailored safety and identification solutions, and integration of recent acquisitions (Gravotech and Mecco) to enhance product offerings and drive growth.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividends Paid: $96 million returned to shareholders through dividends and share buybacks in fiscal 2025.
Dividend Increase: Announced the 40th consecutive year of annual dividend increases.
Share Buybacks: Repurchased 733,000 shares for $51 million in fiscal 2025.
Share Buybacks in Q4: Repurchased 257,000 shares for $17.7 million in the fourth quarter of fiscal 2025.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How does the company plan to achieve significant EPS growth despite challenges in the current environment?
A:The company has taken significant costs out of its structure in the last two quarters, which will contribute to EPS growth. Additionally, they have implemented mitigating strategies to address tariff costs, such as reshoring and supply chain adjustments. They have also pushed through a price increase in June, which is expected to show effects in the coming months.
Q:Why was free cash flow in Q4 lower than usual, and how does this affect the outlook for next year?
A:The lower free cash flow in Q4 was primarily due to inventory build-up caused by moving three large facilities. This included transitioning to new or newly leased facilities and closing a facility in Buffalo. The cash impact of these actions will continue into the first quarter of next year but will be resolved by then.
Q:What is the company's expectation for R&D spending next year, and how do recent acquisitions impact this?
A:The company does not have a fixed target for R&D as a percentage of sales but evaluates opportunities and investments on a project basis. Recent acquisitions like microfluidics with Funai will serve as a core R&D platform, while Mecco is expected to be immediately additive with cost synergies. R&D spending may slightly decrease in the short term as R&D teams are merged but is expected to trend upward in the long term.
Q:How will the incremental tariff impact in 2026 be distributed, and is it included in the guidance?
A:The incremental tariff impact of $8 million to $12 million in 2026 is expected to be more heavily weighted in the first half of the year. The company's mitigation efforts are included in the guidance.
Q:What percentage of the business is made up of printers and cartridges, and what are the key growth areas?
A:Printers and cartridges make up just under 40% of the business. Key growth areas include wire markers, driven by data centers and aerospace and defense sectors, particularly the defense side.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct answer to the specific cadence of R&D spending, stating that it may slightly decrease in the short term but emphasizing a long-term upward trend without committing to specific figures. Additionally, the response to the question about the distribution of tariff impacts was somewhat vague, describing it as a 'bouncing ball' and 'nuanced,' without providing precise details.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Accounting Officer
CFO Chief
Chief Accounting
Funai Microfluidics
Gravotech Funai
Microfluidics Solutions
Officer Treasurer
RD investment
RD sale
SGA
Solutions product
acquisition Gravotech
action
automation
closure reorganization
commitment
element capital
facility closure
head count
high sale
increase milestone
investment RD
price share
printer sale
product printer
record share
region sale
safety identification
sale investment
solution
tariff
trade
BRC Transcript
Brady Corporation (BRC) Q3 2026 Earnings Call Transcript
Positive5-18
The earnings call revealed strong financial performance, including record EPS growth and improved profitability. The Q&A highlighted robust organic growth, a promising new product, and a potentially lucrative acquisition. However, some management responses lacked clarity, and there are risks like economic slowdown and currency fluctuations. Despite these, the positive financial results, increased guidance, and strategic acquisition suggest a positive stock price movement, especially given the company's moderate market cap.
Brady Corporation (BRC) Q2 2026 Earnings Call Transcript
Positive2-19
The earnings call indicates strong financial performance with a 7.7% sales growth and improved profit margins. Despite some concerns about organic sales growth in the Americas, the company shows resilience with significant R&D investment and a strategic shift towards higher-margin engineered products. Positive sentiment is further supported by increased EPS guidance and robust cash flow. While there are some uncertainties, particularly in Europe, the overall outlook remains optimistic, justifying a positive stock price movement prediction.
Brady Corporation (BRC) Q1 2026 Earnings Call Transcript
Positive11-17
The earnings call summary shows strong financial performance with increased net income, operating cash flow, and free cash flow. The Q&A section reveals positive sentiment, with management addressing gross margin improvements, R&D investments, and potential synergies from acquisitions. Despite some uncertainties in inventory management and regional performance, the overall guidance and financial metrics are optimistic. Considering the company's market cap, the stock price is likely to experience a positive movement of 2% to 8% over the next two weeks.
Brady Corporation (BRC) Q4 2025 Earnings Call Transcript
Positive9-4
The company reported strong financial metrics, including record EPS growth and successful acquisitions, despite some challenges in Europe and Australia. The 40th consecutive year of dividend increases and share buybacks signal strong shareholder returns. Although gross margins declined slightly, the company's strategic cost-cutting and tariff mitigation efforts are promising. The Q&A reveals management's confidence in addressing challenges, despite some vague responses. Considering the company's market cap, these factors suggest a positive stock price movement in the short term.
BRC Slides
BRC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
